<DOC>
	<DOCNO>NCT02682420</DOCNO>
	<brief_summary>Prospective , multi-center study evaluate everlinQ endoAVF System use create endovascular arteriovenous fistula ( endoAVF ) patient require vascular access hemodialysis .</brief_summary>
	<brief_title>everlinQ endoAVF Europe ( EU ) Study</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Adult ( age &gt; 18 year old ) Established , nonreversible kidney failure require hemodialysis ( stage 4 5 renal disease ) include predialysis patient Both radial ulnar artery flow hand Known central venous stenosis central vein narrow &gt; 50 % Occlusion stenosis &gt; 50 % target cannulation cephalic basilic vein Significantly compromise ( ≥50 % stenosis ) flow treatment arm Documented ejection fraction ( EF ) ≤35 % last 6 month Pregnant woman New York Heart Association ( NYHA ) class III IV heart failure Hypercoagulable state Known bleeding diathesis Known allergy contrast dye adequately premedicated Known adverse effect sedation and/or anesthesia adequately premedicated</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>